个性化干预配合中等长度导管静脉治疗肾移植受者腹泻疗效观察

Clinical Efficacy of Personalized Intervention Combined with Medium-Length Catheter Intravenous Treatment for Diarrhea in Renal Transplant Recipients

目的探讨个性化干预配合中等长度导管静脉治疗肾移植受者腹泻的临床疗效。方法选取医院肾移植中心2021年1月至2023年12月收治的肾移植受者术后腹泻患者56例,按随机数字表法分为对照组和观察组,各28例。对照组按常规中等长度导管静脉治疗,观察组采用个性化干预配合中等长度导管静脉治疗,比较两组患者干预前后的体质量、体质量指数、腹泻次数,生化检验指标血肌酐、血钾、血钠,导管相关并发症、生活质量的变化。结果观察组患者的体质量、体质量指数、腹泻次数均显著优于对照组(P<0.05);观察组患者的血肌酐、血钾、血钠水平均显著优于对照组(P<0.05);观察组患者的饮食行为、治疗行为、躯体活动及社会心理行为均显著优于对照组(P<0.05)。结论个性化干预配合中等长度导管静脉治疗肾移植受者术后腹泻,可改善患者的腹泻检验指标及生活质量,促进整体恢复。

Objective To investigate the clinical efficacy of personalized intervention combined with medium-length catheter intravenous treatment for diarrhea in renal transplant recipients.Methods A total of 56 patients with postoperative diarrhea underwent renal transplant admitted to the renal transplant center of the hospital from January 2021 to December 2023 were selected and divided into the control group and the observation group according to the random number table method,with 28 cases in each group.The control group was given conventional medium-length catheter intravenous therapy,and the observation group was given personalized intervention combined with medium-length catheter intravenous therapy,the changes in body mass,body mass index,frequence of diarrhea,blood creatinine,blood potassium,blood sodium,catheter-related complications,and quality of life of the patients in the two groups before and after the intervention were compared.Results The body mass,body mass index,and the frequence of diarrhea in the observation group were significantly better than those in the control group(P<0.05).The blood creatinine,blood potassium,and blood sodium levels in the observation group were significantly better than those in the control group(P<0.05).The dietary behaviors,therapeutic behaviors,physical activities,and psychosocial behaviors in the observation group were significantly better than those in the control group(P<0.05).Conclusion Personalized intervention combined with medium-length catheter intravenous treatment for diarrhea in renal transplant recipients can improve patients'diarrhea test indicators and quality of life,and promote overall recovery.